Nicotinamide Mononucleotide (NMN) is a bioactive nucleotide derived from niacin (vitamin B3) and is a direct precursor to NAD⁺ (nicotinamide adenine dinucleotide), a vital coenzyme involved in cellular energy production, DNA repair, and metabolic regulation. As we age, NAD⁺ levels decline significantly, leading to decreased mitochondrial function and increased signs of aging.
Supplementing with NMN has gained significant interest for its potential anti-aging, energy-boosting, and neuroprotective effects. Research suggests NMN may enhance physical endurance, improve insulin sensitivity, support cardiovascular health, and protect against age-related cognitive decline. It is often marketed in capsule or powder form and appeals to health-conscious consumers, especially in regions with aging populations such as Japan, South Korea, and parts of Europe.
For formulators, NMN offers high stability, good oral bioavailability, and compatibility with other longevity ingredients like resveratrol, quercetin, and pterostilbene. As demand grows in the anti-aging and nutraceutical markets, NMN continues to be a promising compound in the global wellness industry.
关键字： anti-aging;Nutrition;
武汉恒和达生物医药有限公司成立于2013年，公司总部位于武汉经济技术开发区民营科技工业园，为湖北省高新技术企业，主要从事原料药、高端医药中间体和精细化工产品的研发与生产，以及新化合物的技术咨询和检测等服务。恒和达生物目前拥有1000平米的研发及中试平台，并配备了各种现代化的实验研究设备，满足了各种化合物的小试研究，中试放大的生产。合作生产基地占地30余亩，配备了成套大型不锈钢和搪玻璃生产设备，反应釜设备从50L到2000L不等，具有吨位级的研发生产能力。